Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
At-Home Testing for Infectious Diseases: The Laboratory Where You Live.

Clinical chemistry

Jean S, Burnham CD, Chapin K, Garner OB, Pant Pai N, Turabelidze G, Butler-Wu S.
PMID: 34969103
Clin Chem. 2021 Dec 30;68(1):19-26. doi: 10.1093/clinchem/hvab198.

No abstract available.

Cite
Jean S, Burnham CD, Chapin K, et al. At-Home Testing for Infectious Diseases: The Laboratory Where You Live. Clin Chem. 2021;68(1):19-26doi: 10.1093/clinchem/hvab198.
Jean, S., Burnham, C. D., Chapin, K., Garner, O. B., Pant Pai, N., Turabelidze, G., & Butler-Wu, S. (2021). At-Home Testing for Infectious Diseases: The Laboratory Where You Live. Clinical chemistry, 68(1), 19-26. https://doi.org/10.1093/clinchem/hvab198
Jean, Sophonie, et al. "At-Home Testing for Infectious Diseases: The Laboratory Where You Live." Clinical chemistry vol. 68,1 (2021): 19-26. doi: https://doi.org/10.1093/clinchem/hvab198
Jean S, Burnham CD, Chapin K, Garner OB, Pant Pai N, Turabelidze G, Butler-Wu S. At-Home Testing for Infectious Diseases: The Laboratory Where You Live. Clin Chem. 2021 Dec 30;68(1):19-26. doi: 10.1093/clinchem/hvab198. PMID: 34969103.
Copy Download .nbib Format: NLM
Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS.

Frontiers in microbiology

Lau AF, Walchak RC, Miller HB, Slechta ES, Kamboj K, Riebe K, Robertson AE, Gilbreath JJ, Mitchell KF, Wallace MA, Bryson AL, Balada-Llasat JM, Bulman A, Buchan BW, Burnham CD, Butler-Wu S, Desai U, Doern CD, Hanson KE, Henderson CM, Kostrzewa M, Ledeboer NA, Maier T, Pancholi P, Schuetz AN, Shi G, Wengenack NL, Zhang SX, Zelazny AM, Frank KM.
PMID: 31616388
Front Microbiol. 2019 Sep 20;10:2098. doi: 10.3389/fmicb.2019.02098. eCollection 2019.

OBJECTIVES: Rapid and accurate mold identification is critical for guiding therapy for mold infections. MALDI-TOF MS has been widely adopted for bacterial and yeast identification; however, few clinical laboratories have applied this technology for routine mold identification due to...

Cite
Lau AF, Walchak RC, Miller HB, et al. Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS. Front Microbiol. 2019;10:2098doi: 10.3389/fmicb.2019.02098.
Lau, A. F., Walchak, R. C., Miller, H. B., Slechta, E. S., Kamboj, K., Riebe, K., Robertson, A. E., Gilbreath, J. J., Mitchell, K. F., Wallace, M. A., Bryson, A. L., Balada-Llasat, J. M., Bulman, A., Buchan, B. W., Burnham, C. D., Butler-Wu, S., Desai, U., Doern, C. D., Hanson, K. E., Henderson, C. M., Kostrzewa, M., Ledeboer, N. A., Maier, T., Pancholi, P., Schuetz, A. N., Shi, G., Wengenack, N. L., Zhang, S. X., Zelazny, A. M., & Frank, K. M. (2019). Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS. Frontiers in microbiology, 102098. https://doi.org/10.3389/fmicb.2019.02098
Lau, Anna F, et al. "Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS." Frontiers in microbiology vol. 10 (2019): 2098. doi: https://doi.org/10.3389/fmicb.2019.02098
Lau AF, Walchak RC, Miller HB, Slechta ES, Kamboj K, Riebe K, Robertson AE, Gilbreath JJ, Mitchell KF, Wallace MA, Bryson AL, Balada-Llasat JM, Bulman A, Buchan BW, Burnham CD, Butler-Wu S, Desai U, Doern CD, Hanson KE, Henderson CM, Kostrzewa M, Ledeboer NA, Maier T, Pancholi P, Schuetz AN, Shi G, Wengenack NL, Zhang SX, Zelazny AM, Frank KM. Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS. Front Microbiol. 2019 Sep 20;10:2098. doi: 10.3389/fmicb.2019.02098. eCollection 2019. PMID: 31616388; PMCID: PMC6764242.
Copy Download .nbib Format: NLM
Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients.

Antimicrobial resistance and infection control

Boyle NM, Magaret A, Stednick Z, Morrison A, Butler-Wu S, Zerr D, Rogers K, Podczervinski S, Cheng A, Wald A, Pergam SA.
PMID: 26473030
Antimicrob Resist Infect Control. 2015 Oct 14;4:41. doi: 10.1186/s13756-015-0081-4. eCollection 2015.

BACKGROUND: Although hematopoietic cell transplant (HCT) recipients are routinely exposed to classic risk factors for Clostridium difficile infection (CDI), few studies have assessed CDI risk in these high-risk patients, and data are especially lacking for pediatric HCT recipients. We...

Cite
Boyle NM, Magaret A, Stednick Z, et al. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrob Resist Infect Control. 2015;4:41doi: 10.1186/s13756-015-0081-4.
Boyle, N. M., Magaret, A., Stednick, Z., Morrison, A., Butler-Wu, S., Zerr, D., Rogers, K., Podczervinski, S., Cheng, A., Wald, A., & Pergam, S. A. (2015). Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrobial resistance and infection control, 441. https://doi.org/10.1186/s13756-015-0081-4
Boyle, Nicole M, et al. "Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients." Antimicrobial resistance and infection control vol. 4 (2015): 41. doi: https://doi.org/10.1186/s13756-015-0081-4
Boyle NM, Magaret A, Stednick Z, Morrison A, Butler-Wu S, Zerr D, Rogers K, Podczervinski S, Cheng A, Wald A, Pergam SA. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrob Resist Infect Control. 2015 Oct 14;4:41. doi: 10.1186/s13756-015-0081-4. eCollection 2015. PMID: 26473030; PMCID: PMC4606905.
Copy Download .nbib Format: NLM
Correction: A Year of Infection in the Intensive Care Unit: Prospective Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic Transmissions and Novel Microbiota.

PLoS genetics

Roach DJ, Burton JN, Lee C, Stackhouse B, Butler-Wu SM, Cookson BT, Shendure J, Salipante SJ.
PMID: 28410416
PLoS Genet. 2017 Apr 14;13(4):e1006724. doi: 10.1371/journal.pgen.1006724. eCollection 2017 Apr.

[This corrects the article DOI: 10.1371/journal.pgen.1005413.].

Cite
Roach DJ, Burton JN, Lee C, et al. Correction: A Year of Infection in the Intensive Care Unit: Prospective Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic Transmissions and Novel Microbiota. PLoS Genet. 2017;13(4):e1006724doi: 10.1371/journal.pgen.1006724.
Roach, D. J., Burton, J. N., Lee, C., Stackhouse, B., Butler-Wu, S. M., Cookson, B. T., Shendure, J., & Salipante, S. J. (2017). Correction: A Year of Infection in the Intensive Care Unit: Prospective Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic Transmissions and Novel Microbiota. PLoS genetics, 13(4), e1006724. https://doi.org/10.1371/journal.pgen.1006724
Roach, David J, et al. "Correction: A Year of Infection in the Intensive Care Unit: Prospective Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic Transmissions and Novel Microbiota." PLoS genetics vol. 13,4 (2017): e1006724. doi: https://doi.org/10.1371/journal.pgen.1006724
Roach DJ, Burton JN, Lee C, Stackhouse B, Butler-Wu SM, Cookson BT, Shendure J, Salipante SJ. Correction: A Year of Infection in the Intensive Care Unit: Prospective Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic Transmissions and Novel Microbiota. PLoS Genet. 2017 Apr 14;13(4):e1006724. doi: 10.1371/journal.pgen.1006724. eCollection 2017 Apr. PMID: 28410416; PMCID: PMC5391911.
Copy Download .nbib Format: NLM
[No title available]

JMM case reports

Austin MC, Hallstrand TS, Hoogestraat DR, Balmforth G, Stephens K, Butler-Wu S, Yeung CC.
PMID: 28348752
JMM Case Rep. 2016 Mar 03;3(2):e005025. doi: 10.1099/jmmcr.0.005025. eCollection 2016 Mar.

CASE PRESENTATION: We describe the unexpected finding of CONCLUSION: Whether it represents the sole infectious agent responsible for the miliary lesions or a partially treated co-infection is impossible to determine, but our finding continues to reinforce the importance of...

Cite
Austin MC, Hallstrand TS, Hoogestraat DR, et al. . JMM Case Rep. 2016;3(2):e005025doi: 10.1099/jmmcr.0.005025.
Austin, M. C., Hallstrand, T. S., Hoogestraat, D. R., Balmforth, G., Stephens, K., Butler-Wu, S., & Yeung, C. C. (2016). . JMM case reports, 3(2), e005025. https://doi.org/10.1099/jmmcr.0.005025
Austin, Melissa C, et al. "." JMM case reports vol. 3,2 (2016): e005025. doi: https://doi.org/10.1099/jmmcr.0.005025
Austin MC, Hallstrand TS, Hoogestraat DR, Balmforth G, Stephens K, Butler-Wu S, Yeung CC. . JMM Case Rep. 2016 Mar 03;3(2):e005025. doi: 10.1099/jmmcr.0.005025. eCollection 2016 Mar. PMID: 28348752; PMCID: PMC5330220.
Copy Download .nbib Format: NLM
[No title available]

Open forum infectious diseases

Rahmati E, Martin V, Wong D, Sattler F, Petterson J, Ward P, Butler-Wu SM, She RC.
PMID: 28480264
Open Forum Infect Dis. 2017 Jan 09;4(1):ofw272. doi: 10.1093/ofid/ofw272. eCollection 2017.

No abstract available.

Cite
Rahmati E, Martin V, Wong D, et al. . Open Forum Infect Dis. 2017;4(1):ofw272doi: 10.1093/ofid/ofw272.
Rahmati, E., Martin, V., Wong, D., Sattler, F., Petterson, J., Ward, P., Butler-Wu, S. M., & She, R. C. (2017). . Open forum infectious diseases, 4(1), ofw272. https://doi.org/10.1093/ofid/ofw272
Rahmati, Elham, et al. "." Open forum infectious diseases vol. 4,1 (2017): ofw272. doi: https://doi.org/10.1093/ofid/ofw272
Rahmati E, Martin V, Wong D, Sattler F, Petterson J, Ward P, Butler-Wu SM, She RC. . Open Forum Infect Dis. 2017 Jan 09;4(1):ofw272. doi: 10.1093/ofid/ofw272. eCollection 2017. PMID: 28480264; PMCID: PMC5414014.
Copy Download .nbib Format: NLM
Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study.

Open forum infectious diseases

Wald-Dickler N, Lee TC, Tangpraphaphorn S, Butler-Wu SM, Wang N, Degener T, Kan C, Phillips MC, Cho E, Canamar C, Holtom P, Spellberg B.
PMID: 35036466
Open Forum Infect Dis. 2021 Dec 23;9(1):ofab620. doi: 10.1093/ofid/ofab620. eCollection 2022 Jan.

BACKGROUND: We sought to determine the comparative efficacy of fosfomycin vs ertapenem for outpatient treatment of complicated urinary tract infections (cUTIs).METHODS: We conducted a multicenter, retrospective cohort study involving patients with cUTI treated with outpatient oral fosfomycin vs intravenous...

Cite
Wald-Dickler N, Lee TC, Tangpraphaphorn S, et al. Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study. Open Forum Infect Dis. 2021;9(1):ofab620doi: 10.1093/ofid/ofab620.
Wald-Dickler, N., Lee, T. C., Tangpraphaphorn, S., Butler-Wu, S. M., Wang, N., Degener, T., Kan, C., Phillips, M. C., Cho, E., Canamar, C., Holtom, P., & Spellberg, B. (2022). Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study. Open forum infectious diseases, 9(1), ofab620. https://doi.org/10.1093/ofid/ofab620
Wald-Dickler, Noah, et al. "Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study." Open forum infectious diseases vol. 9,1 (2022): ofab620. doi: https://doi.org/10.1093/ofid/ofab620
Wald-Dickler N, Lee TC, Tangpraphaphorn S, Butler-Wu SM, Wang N, Degener T, Kan C, Phillips MC, Cho E, Canamar C, Holtom P, Spellberg B. Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study. Open Forum Infect Dis. 2021 Dec 23;9(1):ofab620. doi: 10.1093/ofid/ofab620. eCollection 2022 Jan. PMID: 35036466; PMCID: PMC8754378.
Copy Download .nbib Format: NLM
Closing the Brief Case: Bacteremia Caused by Helicobacter cinaedi.

Journal of clinical microbiology

Bateman AC, Butler-Wu SM.
PMID: 28031451
J Clin Microbiol. 2016 Dec 28;55(1):347-348. doi: 10.1128/JCM.02935-15. Print 2017 Jan.

No abstract available.

Cite
Bateman AC, Butler-Wu SM. Closing the Brief Case: Bacteremia Caused by Helicobacter cinaedi. J Clin Microbiol. 2016;55(1):347-348doi: 10.1128/JCM.02935-15.
Bateman, A. C., & Butler-Wu, S. M. (2017). Closing the Brief Case: Bacteremia Caused by Helicobacter cinaedi. Journal of clinical microbiology, 55(1), 347-348. https://doi.org/10.1128/JCM.02935-15
Bateman, Allen C, and Butler-Wu, Susan M. "Closing the Brief Case: Bacteremia Caused by Helicobacter cinaedi." Journal of clinical microbiology vol. 55,1 (2017): 347-348. doi: https://doi.org/10.1128/JCM.02935-15
Bateman AC, Butler-Wu SM. Closing the Brief Case: Bacteremia Caused by Helicobacter cinaedi. J Clin Microbiol. 2016 Dec 28;55(1):347-348. doi: 10.1128/JCM.02935-15. Print 2017 Jan. PMID: 28031451; PMCID: PMC5228257.
Copy Download .nbib Format: NLM
In Reply.

Clinical chemistry

Bryan A, Baird G, Butler-Wu S.
PMID: 27440510
Clin Chem. 2016 Sep;62(9):1277. doi: 10.1373/clinchem.2016.260984. Epub 2016 Jul 20.

No abstract available.

Cite
Bryan A, Baird G, Butler-Wu S. In Reply. Clin Chem. 2016;62(9):1277doi: 10.1373/clinchem.2016.260984.
Bryan, A., Baird, G., & Butler-Wu, S. (2016). In Reply. Clinical chemistry, 62(9), 1277. https://doi.org/10.1373/clinchem.2016.260984
Bryan, Andrew, et al. "In Reply." Clinical chemistry vol. 62,9 (2016): 1277. doi: https://doi.org/10.1373/clinchem.2016.260984
Bryan A, Baird G, Butler-Wu S. In Reply. Clin Chem. 2016 Sep;62(9):1277. doi: 10.1373/clinchem.2016.260984. Epub 2016 Jul 20. PMID: 27440510.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries